Insider Chart Past 6 Months
Technical Chart
Filings by transaction date
- Jan 15, 2021 (filed on Jan 20, 2021)Insider Name:Pramoda AnitaOwnership Type:Direct OwnershipSecurities:Stock Option (Right to Buy)Nature of Transaction:M - Exercise or conversion exempt under rule 16b-3# or value acquired/disposed of:-7,500Price:--
- Jan 15, 2021 (filed on Jan 20, 2021)Insider Name:Pramoda AnitaOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-16,500Price:$48.09
- Jan 15, 2021 (filed on Jan 20, 2021)Insider Name:Pramoda AnitaOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-7,500Price:$48.04
- Jan 15, 2021 (filed on Jan 20, 2021)Insider Name:Pramoda AnitaOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-1,247Price:$48.00
- Jan 15, 2021 (filed on Jan 20, 2021)Insider Name:Pramoda AnitaOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-8,753Price:$48.05
- Jan 15, 2021 (filed on Jan 20, 2021)Insider Name:Pramoda AnitaOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:M - Exercise or conversion exempt under rule 16b-3# or value acquired/disposed of:16,500Price:$10.40
- Jan 15, 2021 (filed on Jan 20, 2021)Insider Name:Pramoda AnitaOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:M - Exercise or conversion exempt under rule 16b-3# or value acquired/disposed of:8,753Price:$10.66
- Jan 15, 2021 (filed on Jan 20, 2021)Insider Name:Pramoda AnitaOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:M - Exercise or conversion exempt under rule 16b-3# or value acquired/disposed of:7,500Price:$10.66
- Jan 15, 2021 (filed on Jan 20, 2021)Insider Name:Pramoda AnitaOwnership Type:Direct OwnershipSecurities:Stock Option (Right to Buy)Nature of Transaction:M - Exercise or conversion exempt under rule 16b-3# or value acquired/disposed of:-16,500Price:--
- Jan 15, 2021 (filed on Jan 20, 2021)Insider Name:Pramoda AnitaOwnership Type:Direct OwnershipSecurities:Stock Option (Right to Buy)Nature of Transaction:M - Exercise or conversion exempt under rule 16b-3# or value acquired/disposed of:-1,247Price:--
Filings by filing date
- Jan 15, 2021 (filed on Jan 20, 2021)Insider Name:Pramoda AnitaOwnership Type:Direct OwnershipSecurities:Stock Option (Right to Buy)Nature of Transaction:M - Exercise or conversion exempt under rule 16b-3# or value acquired/disposed of:-7,500Price:--
- Jan 15, 2021 (filed on Jan 20, 2021)Insider Name:Pramoda AnitaOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-16,500Price:$48.09
- Jan 15, 2021 (filed on Jan 20, 2021)Insider Name:Pramoda AnitaOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-7,500Price:$48.04
- Jan 15, 2021 (filed on Jan 20, 2021)Insider Name:Pramoda AnitaOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-1,247Price:$48.00
- Jan 15, 2021 (filed on Jan 20, 2021)Insider Name:Pramoda AnitaOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-8,753Price:$48.05
- Jan 15, 2021 (filed on Jan 20, 2021)Insider Name:Pramoda AnitaOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:M - Exercise or conversion exempt under rule 16b-3# or value acquired/disposed of:16,500Price:$10.40
- Jan 15, 2021 (filed on Jan 20, 2021)Insider Name:Pramoda AnitaOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:M - Exercise or conversion exempt under rule 16b-3# or value acquired/disposed of:8,753Price:$10.66
- Jan 15, 2021 (filed on Jan 20, 2021)Insider Name:Pramoda AnitaOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:M - Exercise or conversion exempt under rule 16b-3# or value acquired/disposed of:7,500Price:$10.66
- Jan 15, 2021 (filed on Jan 20, 2021)Insider Name:Pramoda AnitaOwnership Type:Direct OwnershipSecurities:Stock Option (Right to Buy)Nature of Transaction:M - Exercise or conversion exempt under rule 16b-3# or value acquired/disposed of:-16,500Price:--
- Jan 15, 2021 (filed on Jan 20, 2021)Insider Name:Pramoda AnitaOwnership Type:Direct OwnershipSecurities:Stock Option (Right to Buy)Nature of Transaction:M - Exercise or conversion exempt under rule 16b-3# or value acquired/disposed of:-1,247Price:--
News
Biz Brief
Sector: Healthcare | Industry: Advanced Medical Equipment & Technology |
See Regulatory Filings on SEC |
Company Contact | |
Address: | 3165 E Millrock Dr Ste 400 SALT LAKE CITY UT 84121-4772 |
Tel: | 1-855-3096800 |
Website: | https://www.healthcatalyst.com |
IR: | See website |
Key People | ||
Fraser Bullock Independent Chairman of the Board | J. Patrick Nelli President | Daniel D. Burton Chief Executive Officer, Director |
Bryan Hunt Chief Financial Officer | Paul Horstmeier Chief Operating Officer | Linda Llewelyn Chief People Officer |
Jason Alger Chief Accounting Officer | Amanda Hundt Vice President - Corporate Communications | Daniel H. Orenstein General Counsel, Corporate Secretary |
Business Overview |
Health Catalyst Inc. is a provider of data and analytics technology and services to healthcare organizations. Its solution comprises a cloud-based data platform, analytics software, and professional services expertise. Its cloud-based data operating system (DOS) is a healthcare-specific, open, flexible, and scalable data platform that provides customers a single comprehensive environment to integrate and organize data from their disparate software systems, enabling a broad range of analytics. Its software analytics application is build on top of its data platform to provide foundational or domain-specific insights that improve customers' clinical, financial, and operational performance. It serves the majority of customers through a subscription-based contract model. Its offered services include opportunity analysis and prioritization, data modeling and analysis, quality and process improvement strategy, and population health strategies. It offers its services to healthcare providers. |
Financial Overview |
For the nine months ended 30 September 2020, HealthCatalyst Inc revenues increased 22% to $135.6M. Net lossapplicable to common stockholders decreased 68% to $72M.Revenues reflect Technology segment increase of 27% to$78.2M, Professional Services segment increase of 15% to$57.4M. Lower net loss reflects Sales and marketing -Balancing value decrease of 5% to $30.9M (expense). |
Employees: | 728 as of Mar 31, 2019 |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $1,937M as of Sep 30, 2020 |
Annual revenue (TTM): | $179.07M as of Sep 30, 2020 |
EBITDA (TTM): | -$54.84M as of Sep 30, 2020 |
Net annual income (TTM): | -$86.27M as of Sep 30, 2020 |
Free cash flow (TTM): | -$39.32M as of Sep 30, 2020 |
Net Debt Last Fiscal Year: | N/A |
Shares outstanding: | 42,498,469 as of Oct 31, 2020 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |